Výsledky vyhledávání - "Radoslaw Formuszewicz"

Akademický článek

Five-year clinical outcomes following drug-eluting stent implantation in left main trifurcations

Autor: Robert J. Gil, Jacek Bil, Adam K. Kern, Luis A. Inigo Garcia, Radoslaw Formuszewicz, Slawomir Dobrzycki

Publikováno v: Advances in Interventional Cardiology, Vol 15, Iss 1, Pp 116-119 (2019)

Externí odkaz: https://doaj.org/article/75c4a485e0c7448abc752be3e41fe7d8

Akademický článek

Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies

Autor: Robert J. Gil, Jacek Bil, Adam Kern, Luis A. Iñigo-Garcia, Radoslaw Formuszewicz, Slawomir Dobrzycki, Dobrin Vassilev, Roxana Mehran

Publikováno v: Cardiovascular Therapeutics, Vol 2020 (2020)

Aim. The marked variation in bifurcation anatomy has brought about an ongoing search for stents specifically constructed for coronary bifurcations. This study aimed to analyze the angiographic restenosis prevalence and patterns and predictors of diff

Externí odkaz: https://doaj.org/article/d109b2eed2f84ed098b2f374717c0e60

Zobrazit plný text záznamu

Plný text ve formátu HTML

6-year results of BiOSS stents in coronary bifurcation treatment

Autor: Robert J. Gil, Adam Kern, Sławomir Dobrzycki, Luis A Iñigo Garcia, Dobrin Vassilev, Radoslaw Formuszewicz, Jacek Bil

Publikováno v: European journal of clinical investigationREFERENCES. 51(8)

Background The wide variation in bifurcation anatomy has generated an ongoing search for stents explicitly designed for coronary bifurcations, and to date, results have been underachieved. Methods The POLBOS I and POLBOS II were international, multic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d3066f3ee86182ba6f51b05ff7ad884
https://pubmed.ncbi.nlm.nih.gov/33782985

Zobrazit plný text záznamu

Predictors of long-term outcomes of coronary bifurcation stenting: 6-year results from international, randomized POLBOS I and POLBOS II clinical trials

Autor: Radoslaw Formuszewicz, Jacek Bil, Robert J. Gil, Sławomir Dobrzycki, Adam Kern, L.A. Inigo Garcia, Dobrin Vassilev

Publikováno v: European Heart Journal. 41

Introduction Bifurcation lesions pose a therapeutic challenge during percutaneous coronary intervention (PCI). Results of regular drug-eluting stents (rDESs) in bifurcation treatment are not optimal. Purpose The aim of this study was to analyze the 6

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::25ee4c40159a4292b46e826d9ed5887d
https://doi.org/10.1093/ehjci/ehaa946.1480

Zobrazit plný text záznamu

Autor: Adam Kern, Sławomir Dobrzycki, Robert J. Gil, Dobrin Vassilev, Roxana Mehran, Luis A. Iñigo-García, Radoslaw Formuszewicz, Jacek Bil

Publikováno v: Cardiovascular Therapeutics, Vol 2020 (2020)
Cardiovascular Therapeutics

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5c063ca4b214887b55cc0605fbbd880
https://doaj.org/article/d109b2eed2f84ed098b2f374717c0e60

Zobrazit plný text záznamu

Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial

Autor: Sławomir Dobrzycki, Radoslaw Formuszewicz, Jacek Bil, Patrick W. Serruys, Luis A Iñigo Garcia, Tomasz Pawłowski, Joanna J. Wykrzykowska, Robert J. Gil, Adam Kern, Dobrin Vassilev, Maik J. Grundeken

Publikováno v: EuroIntervention, 12(11), e1404-e1412. EuroPCR

AIMS The aim of the POLBOS II randomised trial was to compare any regular drug-eluting stents (rDES) with the dedicated bifurcation sirolimus-eluting stent BiOSS LIM for the treatment of coronary bifurcation lesions. The secondary aim was to study th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c086112a6efcf8652607c8f4ddbdd343
https://doi.org/10.4244/eijy15m11_11

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání